Ansyme catalyzes connections between cellular neuroscience and systemic medicine, with a focus on the autonomic nervous system.
The founders of Ansyme are also patients with untreatable chronic conditions like POTS, MCAS, ME/CFS, IBS, and Long COVID. Millions around the world suffer from these and other medical conditions with no reliable way to get relief.
When we found scientists who harnessed brain circuits (in mice) to control some of our symptoms, we went looking for organizations that conducted research into medical applications for this advanced neuroscience.
We didn’t find any.
Ansyme was founded to address this need.
We’re building a community of frontier scientists, physicians, and patients to bring attention to the autonomic nervous system and its impact on medical conditions. Through regular communication, our work promotes new ideas and collaborations. We keep patient outcomes at the forefront of research that might otherwise be considered impractical or inapplicable.
The autonomic nervous system touches nearly every organ in the body. Mounting evidence indicates that it plays a significant role in chronic illnesses and health conditions, yet current medical practice primarily relies on immunological and cardiovascular interventions, many of which aren’t effective. Research funding goes to neuroscience that’s focused on memory, emotion, and cognition rather than the subconscious.
There’s a gap between what’s possible and what’s being done.
We want to bridge that gap.
The science behind what we do
Autonomic neural control circuits have been identified for a handful of the 200+ symptoms that characterize “Long X” syndromes. Our newsletter articles explore these circuits and other neurological mechanisms, as well as their potential applications to medicine. In the long run, this research could apply to numerous conditions, such as chronic Lyme, pain, migraine, irritable bowel, itch, and even cancer.